R. Root Jonathan's Insider Trades & SAST Disclosures
R. Root Jonathan's most recent trade in Harley-Davidson, Inc. was a trade of 1,309 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R. Root Jonathan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 1,309 | 0 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 1,309 | 21,741 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 1,185 | 1,186 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 1,185 | 22,542 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.82 per share. | 09 Feb 2025 | 384 | 21,357 (0%) | 0% | 26.8 | 10,299 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.82 per share. | 09 Feb 2025 | 348 | 22,194 (0%) | 0% | 26.8 | 9,333 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 29,941 | 29,941 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 5,298 | 21,995 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.72 per share. | 06 Feb 2025 | 1,563 | 20,432 (0%) | 0% | 26.7 | 41,763 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 3,168 | 6,337 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2025 | 3,168 | 17,794 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | CFO and President, Commercial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.82 per share. | 05 Feb 2025 | 1,097 | 16,697 (0%) | 0% | 26.8 | 29,422 | Common Stock |
| Edgewise Therapeutics Inc | Jonathan D. Root | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 20,594 | 20,594 | - | - | Stock Option (Right to Buy) | |
| Inari Medical Inc | Jonathan D. Root | Director | Grant, award, or other acquisition of securities at price $ 42.41 per share. | 24 Apr 2024 | 4,126 | 541,149 | - | 42.4 | 174,984 | Common Stock |
| Inari Medical Inc | Jonathan D. Root | Director | Grant, award, or other acquisition of securities at price $ 42.41 per share. | 24 Apr 2024 | 4,126 | 541,149 | - | 42.4 | 174,984 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,308 | 1,309 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Root Jonathan R. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,308 | 14,173 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan Root R. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,184 | 2,371 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Root Jonathan R. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,184 | 14,973 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan Root R. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.85 per share. | 09 Feb 2024 | 384 | 13,789 (0%) | 0% | 36.8 | 14,150 | Common Stock |
| Harley-Davidson, Inc. | R. Root Jonathan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.85 per share. | 09 Feb 2024 | 347 | 14,626 (0%) | 0% | 36.9 | 12,787 | Common Stock |
| Harley-Davidson, Inc. | R. Root Jonathan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 9,505 | 9,505 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | R. Root Jonathan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2024 | 6,997 | 15,013 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Root Jonathan R. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.88 per share. | 05 Feb 2024 | 2,148 | 12,865 (0%) | 0% | 33.9 | 72,774 | Common Stock |
| Harley-Davidson, Inc. | R. Root Jonathan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 1,669 | 8,594 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Root R. Jonathan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2024 | 1,669 | 0 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Root R. Jonathan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.19 per share. | 03 Feb 2024 | 578 | 8,016 (0%) | 0% | 34.2 | 19,762 | Common Stock |
| Inari Medical Inc | Jonathan D. Root | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2023 | 2,982 | 537,023 | - | 0 | Common Stock | |
| Inari Medical Inc | Jonathan D. Root | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2023 | 2,982 | 0 | - | - | Restricted Stock Unit | |
| Inari Medical Inc | Jonathan D. Root | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 2,412 | 534,041 | - | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 3,555 | 3,555 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 1,307 | 6,781 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 1,307 | 2,617 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 739 | 7,137 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. | 09 Feb 2023 | 383 | 6,398 (0%) | 0% | 47.8 | 18,315 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. | 09 Feb 2023 | 212 | 6,925 (0%) | 0% | 47.8 | 10,138 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Sale of securities on an exchange or to another person at price $ 50.17 per share. | 06 Feb 2023 | 2,239 | 5,474 (0%) | 0% | 50.2 | 112,324 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,668 | 7,832 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 1,668 | 1,669 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 702 | 7,956 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 702 | 0 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.31 per share. | 03 Feb 2023 | 578 | 7,254 (0%) | 0% | 51.3 | 29,657 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.31 per share. | 03 Feb 2023 | 243 | 7,713 (0%) | 0% | 51.3 | 12,468 | Common Stock |
| Edgewise Therapeutics Inc | Jonathan D. Root | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 42,087 | 42,087 | - | - | Stock Option (Right to Buy) | |
| Inari Medical Inc | Jonathan D. Root | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 2,983 | 2,982 | - | - | Restricted Stock Unit | |
| Inari Medical Inc | Jonathan D. Root | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2022 | 2,983 | 531,629 | - | 0 | Common Stock | |
| Inari Medical Inc | Jonathan D. Root | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 2,420 | 528,646 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Jonathan D. Root | Director | Other type of transaction at price $ 0.00 per share. | 25 Feb 2022 | 3,473,543 | 0 | - | - | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 3,924 | 3,924 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2022 | 702 | 6,272 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2022 | 702 | 702 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.75 per share. | 05 Feb 2022 | 244 | 6,028 (0%) | 0% | 35.8 | 8,723 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 191 | 6,219 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.75 per share. | 04 Feb 2022 | 55 | 6,164 (0%) | 0% | 35.7 | 1,966 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,668 | 6,148 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 1,668 | 3,337 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.60 per share. | 03 Feb 2022 | 578 | 5,570 (0%) | 0% | 35.6 | 20,577 | Common Stock |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 677 | 0 | - | - | Restricted Stock Units | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 677 | 4,715 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson, Inc. | Jonathan R. Root | SVP - HDFSI | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.92 per share. | 01 Feb 2022 | 235 | 4,480 (0%) | 0% | 35.9 | 8,441 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.68 per share. | 02 Dec 2021 | 7,861 | 4,384,301 | - | 5.7 | 44,650 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.68 per share. | 02 Dec 2021 | 252 | 140,261 | - | 5.7 | 1,431 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.53 per share. | 29 Nov 2021 | 26,559 | 4,410,810 | - | 6.5 | 173,483 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.70 per share. | 29 Nov 2021 | 24,965 | 4,437,369 | - | 6.7 | 167,141 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.44 per share. | 29 Nov 2021 | 18,648 | 4,392,162 | - | 6.4 | 120,037 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.53 per share. | 29 Nov 2021 | 850 | 141,110 | - | 6.5 | 5,553 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.69 per share. | 29 Nov 2021 | 799 | 141,960 | - | 6.7 | 5,349 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 6.44 per share. | 29 Nov 2021 | 597 | 140,513 | - | 6.4 | 3,843 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.36 per share. | 23 Nov 2021 | 35,388 | 4,467,204 | - | 7.4 | 260,279 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 23 Nov 2021 | 14,418 | 4,502,592 | - | 7.4 | 106,736 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 23 Nov 2021 | 4,870 | 4,462,334 | - | 7.0 | 34,148 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.36 per share. | 23 Nov 2021 | 1,132 | 142,915 | - | 7.4 | 8,326 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.40 per share. | 23 Nov 2021 | 461 | 144,047 | - | 7.4 | 3,413 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 23 Nov 2021 | 156 | 142,759 | - | 7.0 | 1,093 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.86 per share. | 18 Nov 2021 | 25,371 | 4,517,010 | - | 7.9 | 199,416 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 18 Nov 2021 | 16,226 | 4,549,398 | - | 8.5 | 138,375 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.12 per share. | 18 Nov 2021 | 7,017 | 4,542,381 | - | 8.1 | 56,985 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.86 per share. | 18 Nov 2021 | 812 | 144,508 | - | 7.9 | 6,382 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.53 per share. | 18 Nov 2021 | 519 | 145,544 | - | 8.5 | 4,426 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 8.12 per share. | 18 Nov 2021 | 224 | 145,320 | - | 8.1 | 1,819 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.13 per share. | 15 Nov 2021 | 9,918 | 4,565,624 | - | 9.1 | 90,522 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.42 per share. | 15 Nov 2021 | 8,062 | 4,575,542 | - | 9.4 | 75,936 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.81 per share. | 15 Nov 2021 | 4,914 | 4,583,604 | - | 9.8 | 48,211 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.13 per share. | 15 Nov 2021 | 317 | 146,063 | - | 9.1 | 2,894 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.42 per share. | 15 Nov 2021 | 257 | 146,380 | - | 9.4 | 2,421 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 9.81 per share. | 15 Nov 2021 | 157 | 146,637 | - | 9.8 | 1,540 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.44 per share. | 09 Nov 2021 | 32,946 | 4,611,790 | - | 10.4 | 343,824 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 09 Nov 2021 | 27,892 | 4,644,736 | - | 11.0 | 306,924 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.37 per share. | 09 Nov 2021 | 11,644 | 4,600,146 | - | 10.4 | 120,725 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.07 per share. | 09 Nov 2021 | 11,628 | 4,588,518 | - | 10.1 | 117,094 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.44 per share. | 09 Nov 2021 | 1,054 | 147,539 | - | 10.4 | 11,000 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 09 Nov 2021 | 893 | 148,593 | - | 11.0 | 9,827 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.37 per share. | 09 Nov 2021 | 373 | 147,166 | - | 10.4 | 3,867 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 10.07 per share. | 09 Nov 2021 | 372 | 146,794 | - | 10.1 | 3,746 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 3,981,940 | 3,981,940 | - | - | Common Stock | |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 25 Aug 2021 | 690,688 | 4,672,628 | - | 10 | 6,906,880 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 586,573 | 586,573 | - | - | Earn-out Right | |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 127,389 | 127,389 | - | - | Common Stock | |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 25 Aug 2021 | 22,097 | 149,486 | - | 10 | 220,970 | Common Stock |
| eFFECTOR Therapeutics Inc | Jonathan D. Root | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2021 | 18,765 | 18,765 | - | - | Earn-out Right |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges